inWhite tw_white-black
MoreMenu
CloseWhite
inWhite tw_white-black

News

Eurostars-funded REPRINT consortium reaches milestones with evidence of complete tumor regression induced by dendritic cell reprogramming

Asgard Therapeutics Announces Appointment of Three Members to its Newly Formed Scientific Advisory Board (SAB)

Asgard Therapeutics appoints Martin Bonde as Independent Chair of the Board of Directors

Asgard Therapeutics Granted U.S. Patent for Dendritic Cell Reprogramming

Cristiana Pires CEO discusses the increasing traction of cellular reprogramming within the investor community in Portuguese newspaper Expresso.

Posted 25 January, 2022